GCI Health

GCI Health is a global healthcare communications and engagement agency specializing in pharmaceutical, biotechnology, and healthcare brand communications. The agency positions itself as a "health impact agency" focused on translating complex science into accessible communications and delivering data-driven engagement strategies across the healthcare spectrum.

The agency operates through a global network of offices spanning North America, Europe, Asia-Pacific, and the Middle East. Their service portfolio includes clinical trial recruitment communications, product launches, disease awareness campaigns, corporate reputation management, and content development through their Content Collaborative team. GCI Health emphasizes local market expertise combined with global capabilities, particularly for pharmaceutical and biotechnology clients navigating product milestones and stakeholder engagement.

The agency has received recognition including PRovoke Media's Best Agency designation for 2025 in the U.S. and UK, PR Week's Best Public Health Awareness Campaign in 2024, and MM+M's Agency of the Year in 2021. Their leadership team brings decades of healthcare communications experience across therapeutic areas and global markets.

Healthcare organizations should consider GCI Health when they require global communications capabilities with local execution, particularly for pharmaceutical product launches or clinical trial initiatives requiring multi-market coordination. The agency's strength lies in translating complex scientific information into stakeholder-appropriate messaging across professional and consumer audiences.

Expect a strategic approach emphasizing accountability and real-world outcomes rather than impressions-based metrics. The agency's integrated content capabilities and therapeutic area expertise make them well-suited for organizations navigating regulatory requirements while building brand awareness and reputation across diverse stakeholder groups.

GCI Health operates exclusively in healthcare communications, describing themselves as working "from molecules to the masses" across the healthcare spectrum. The agency serves pharmaceutical and biotechnology companies through all stages of the product lifecycle, including clinical development, regulatory milestones, and commercial launches. Their healthcare expertise spans therapeutic area communications, patient advocacy engagement, disease awareness campaigns, and professional stakeholder relations.

The agency demonstrates specific healthcare vertical knowledge through services like clinical trial recruitment communications, pharmaceutical product launch strategies, and navigation of healthcare regulatory environments across global markets. Their leadership team has specialized experience in U.S. and global pharmaceutical communications, biosimilars, and conventional and biologic therapies.

The ideal client is a mid-to-large pharmaceutical company, biotechnology firm, or healthcare organization managing complex, multi-stakeholder communications across global markets. Organizations launching new therapies, managing clinical trial recruitment, or building corporate reputation in the life sciences space will find aligned capabilities, particularly those requiring regulatory navigation and scientific credibility in their communications.